{
    "code": 0,
    "data": [
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.",
            "news_id": "fe91fd2a-59ca-47f5-87b5-d2419454000b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b8547b-3699-4956-b982-474f88ea4a53.pdf",
            "news_date": "2026-01-30 18:43:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q3 FY2025-26 Earnings Call held on January 22 2026 on the website of the Company at:\r\nhttps://www.alivus.com/alivus_pdfs/investors/financials/reports_presentation/10039101.mp3",
            "news_id": "0cb5a0b0-c6d0-48c1-8e57-eb04d193ae53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da60cf05-a6ac-4426-8c8b-c833afce6850.pdf",
            "news_date": "2026-01-22 19:59:36",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investors Presentation - Q3 FY 25-26.",
            "news_id": "a4fdd875-e32e-4265-9b45-b3c3bb00e543",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=512b006a-0a27-4139-9724-eba7013ba461.pdf",
            "news_date": "2026-01-22 14:27:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended 31 December 2025.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for the Third Quarter and Nine Months ended 31st December 2025.",
            "news_id": "3d36dcd3-219c-4fa0-be25-8e4e5dfdc263",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=257004bd-fe6e-47bb-99d3-c5b6b7e201a4.pdf",
            "news_date": "2026-01-22 14:05:08",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call.",
            "news_id": "b9939b3b-6aaa-43b1-9fa6-bef27cd7e2c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f8e4217-f830-4a36-8fc3-7582ac309ce9.pdf",
            "news_date": "2025-11-13 11:43:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q2 FY2026 Earnings Call held on November 07 2025 on the website of the Company at:\r\n\r\nhttps://bunny-wp-pullzone-zhbiessutg.b-cdn.net/alivus_pdfs/investors/financials/reports_presentation/10037134.mp3",
            "news_id": "6e27bd36-82b1-442c-a95c-94ce2eb726d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ee542a3-6cf5-4d38-ac35-528c1fe26150.pdf",
            "news_date": "2025-11-07 15:17:26",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Enclosing herewith Investor Presentation - Q2 FY 2025-26.",
            "news_id": "a78b548b-381b-4a9d-9c46-697099daeabf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=456b8f18-4155-43de-b301-ca96c323a1de.pdf",
            "news_date": "2025-11-06 19:28:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results for the Second quarter and Half Year ended September 30 2025.",
            "news_id": "d70d9d80-a330-41a2-9679-6216287c0b2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03c976ff-796d-4b11-8cdc-6c05276745bc.pdf",
            "news_date": "2025-11-06 18:44:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call",
            "news_id": "afc12b25-ec0e-4863-8412-2c18d69090eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2b02e0-9dd7-45cf-9b7e-36dd0e85829a.pdf",
            "news_date": "2025-08-08 16:55:29",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2025-26 Earnings Call",
            "news_id": "e36106aa-d341-483c-bd8e-08b955fd20a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6caea94-c20b-45cd-b0c4-d48165f6619a.pdf",
            "news_date": "2025-08-02 12:24:11",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "2781b590-687f-4ada-842e-148468277611",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c28a52f-fa3c-4117-9f2f-6a4cb2351915.pdf",
            "news_date": "2025-08-01 19:14:42",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30 2025",
            "news_body": "Please find attached herewith Unaudited Financial Results for the First Quarter Ended 30 June 2025",
            "news_id": "7ef95d44-7f4c-4215-a1dd-64fd80c97a01",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=698425f2-b287-4aa8-9ee0-db5d3dc8b678.pdf",
            "news_date": "2025-08-01 19:01:12",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith Earnings Call Transcript.",
            "news_id": "1d99986d-9a45-4239-aa0d-cc372c77082d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79318563-47a8-499a-990a-1e34b991aea7.pdf",
            "news_date": "2025-05-23 16:08:33",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4 & FY2024-25 Earnings Call",
            "news_id": "1d7c7f7a-5cf9-4261-8014-01a6c8497511",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ad8557d-8703-4fd4-a37c-e358335e5d40.pdf",
            "news_date": "2025-05-16 12:59:43",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclose herewith Press Release of the Company for the Fourth Quarter and Year Ended March 31 2025",
            "news_id": "3d0edec2-1b32-4e3b-a09d-62d52d71afa0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad68d0b2-95b0-496b-af6d-7f7b2325e3a8.pdf",
            "news_date": "2025-05-15 21:01:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025",
            "news_body": "Please find enclosed herewith Audited Financial Results for the Fourth Quarter and Year Ended March 31 2025",
            "news_id": "a10f0e76-1ecc-4ee2-a991-8aa8af57b1c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3c3165f-d4bd-4e4b-bd89-cb71e7f1cdd2.pdf",
            "news_date": "2025-05-15 20:28:27",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "a39ae1f5-daa9-4a89-98fd-cda8484e99e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d4a2401-f8d5-40d1-bc29-a9d6a7537501.pdf",
            "news_date": "2025-01-23 14:33:57",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024",
            "news_body": "We would wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine months ended December 31 2024.",
            "news_id": "a6ed047f-c9b4-4c07-a80d-0c191be82491",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e21e6b69-26e5-492f-b7f0-c857d3254ec8.pdf",
            "news_date": "2025-01-23 14:23:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q2 FY2024-25 Earnings Call",
            "news_id": "a144605a-5956-4343-b5d3-17cebac176a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d780dc9a-b5be-4597-953d-9748e5681e09.pdf",
            "news_date": "2024-10-25 17:44:39",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "bbaa3301-1f64-4a4a-8161-6ecf9c487901",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e76d4a86-7399-4723-be60-a7e79244454a.pdf",
            "news_date": "2024-10-24 19:32:25",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Finanacial Results For The Second Quarter And Half Year Ended 30Th September 2024.",
            "news_body": "Please find attached herewith unaudited Finacial Results for the second quarter and half year ended 30th September 2024",
            "news_id": "53889a6f-eb85-4d61-904e-90a4888bd117",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce153b4-0caf-4e40-9583-fd95c6b51220.pdf",
            "news_date": "2024-10-24 18:27:20",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Earning Calls Transcript.",
            "news_id": "ae12a374-686a-44cc-b75c-4ccb93c35f72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d99fa1-82a2-4424-b066-36565368ce9b.pdf",
            "news_date": "2024-08-02 17:40:20",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2024-25 Earnings Call.",
            "news_id": "37356cec-7ac3-4c9f-b8b3-b27d535c9c12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be0d5d30-d90e-4438-b422-14e049b187ac.pdf",
            "news_date": "2024-07-26 17:35:31",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are enclosing herewith the Investor Presentation - Q1 FY 24-25.",
            "news_id": "452d3d8f-746d-4f56-8ae7-ce045cad0389",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90ee7efe-a0f6-4393-9ac0-6923563905d6.pdf",
            "news_date": "2024-07-25 19:58:41",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2024",
            "news_body": "Please find attached unaudited financial result for First Quarter ended June 30, 2024",
            "news_id": "539f1ef1-e25a-4566-ae89-68686833ab6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8645a78-cbce-474a-9f94-74cb940c372e.pdf",
            "news_date": "2024-07-25 19:18:08",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith Earnings Call Transcript.",
            "news_id": "265e017e-307c-4806-8564-f4360fb1b51f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86dbe2fa-8e54-4b3b-bbfa-80979a129a5c.pdf",
            "news_date": "2024-05-03 17:14:02",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4 FY2023-24 Earnings Call",
            "news_id": "ff65fb3a-32b3-4eb7-9ecc-4742e72f4e52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=788eded2-2410-4ba1-8159-b9f5fe42ab44.pdf",
            "news_date": "2024-04-26 16:02:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "03694bad-b9e0-486a-a09f-79cd685c64bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5da7756-cb58-4feb-b494-526ce47cc641.pdf",
            "news_date": "2024-04-25 15:06:31",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results",
            "news_body": "Please Find Attached Audited Financial Results for Quarter and Year ended 31st March 2024",
            "news_id": "09069e75-8b0f-4c5f-b420-96061e5d6b70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4425b5d-9f06-471f-882b-e95c00b92ac0.pdf",
            "news_date": "2024-04-25 14:50:16",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please enclosed find herewith copy of the Investor Presentation.",
            "news_id": "d2acce50-7659-4c77-bf4b-3a98fa2e88eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90aaf027-b5fe-40b6-bd85-eee3788ff1bf.pdf",
            "news_date": "2024-03-11 18:57:37",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call",
            "news_id": "bb91180c-7a2a-45a6-89a6-0817a95d4d9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fbc8804-cd7f-430a-83c6-4ed9abb7b8a3.pdf",
            "news_date": "2024-01-31 22:34:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q3 FY2023-24 Earnings Call held on 24th January, 2024 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320240124150895.mp3",
            "news_id": "98d11902-e25a-48f0-9bed-a239b1cb0244",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd5862d-9595-4774-ad9e-89b1845962d1.pdf",
            "news_date": "2024-01-24 15:45:55",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 - FY 23-24",
            "news_id": "eeda3115-10a3-4ab7-9dad-b2e458bc1eed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c38a984-387a-4b9a-af85-304e4f9fcca0.pdf",
            "news_date": "2024-01-23 17:42:47",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Calls.",
            "news_id": "21ba04dc-2af1-4cbc-861c-2078166c115d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5eefc359-c628-4518-8e3b-054326c34319.pdf",
            "news_date": "2023-10-25 17:50:49",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2023-24 Earnings Call held on 20th October, 2023 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320231020149273.mp3",
            "news_id": "867fe84c-d1d1-4feb-9398-4ee4e7492c9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b66f0b8-80f1-4364-8c8b-57af66bf0241.pdf",
            "news_date": "2023-10-21 15:45:28",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 - FY 23-24",
            "news_id": "a54ae77a-e970-4f15-9b8c-f5e55048edd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76dc2164-9985-4914-96f7-4ddf06fb741d.pdf",
            "news_date": "2023-10-20 13:23:53",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on Friday, July 21, 2023 for the first quarter ended June 30, 2023 is available on the Company''s website. The said transcript is also attached.",
            "news_id": "f9734ced-eafc-44ae-a42f-96732a217bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d87a6b57-d63b-4ebc-bde9-c277fa6c95bb.pdf",
            "news_date": "2023-07-24 16:25:26",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2023-24 Earnings Call",
            "news_id": "6fc1bb26-50d6-4aa6-90b0-59acf5accb60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3dee141c-7319-47e1-8d64-492933e75a78.pdf",
            "news_date": "2023-07-21 22:20:50",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY24",
            "news_id": "883c5e52-3720-45ab-9998-443d49f7916d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3ab243f-0ac2-4c2c-b60d-de95d906488b.pdf",
            "news_date": "2023-07-21 13:13:04",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the First Quarter ended June 30, 2023",
            "news_id": "9e17558d-fc77-48bf-abaa-e12961a6bb2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fefd3e7-5eaa-4dcd-99c9-f5ab661eef6d.pdf",
            "news_date": "2023-07-21 12:55:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, April 28, 2023 for the Fourth quarter and year ended March 31, 2023 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Earnings%20Call%20Transcript_28_April_2023.pdfThe said transcript is also attached.",
            "news_id": "6e29bfe7-d587-4ed1-813c-d81ab7e98c7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec41a636-1e55-4541-8330-ce401d102453.pdf",
            "news_date": "2023-05-02 14:21:17",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q4 FY2022-23 Earnings Call held on 28th April, 2023 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320230428146371.mp3",
            "news_id": "2efeaa1e-8d77-4127-873d-769e4a0eab1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=429e2790-dbf6-4048-a36c-ae1779fcf5b9.pdf",
            "news_date": "2023-04-28 15:13:16",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "8cb99891-1dd3-42c8-9ada-a2a42ed3ddf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c855912-7c32-4231-80fb-a2bf4088b181.pdf",
            "news_date": "2023-04-27 18:19:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2023",
            "news_id": "fd9d8641-5a97-4b2e-bc20-edb95e62bae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=950f6c83-cc58-4bb4-a91f-78ad1921cf02.pdf",
            "news_date": "2023-04-27 17:40:32",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, January 27, 2023 for the Third quarter and Nine Months ended December 31, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Glenmark Life Sciences-Earnings Call Transcript-Jan- 27_2023.pdfThe said transcript is also attached.",
            "news_id": "145b924f-76ee-465b-9dec-10715fd9e211",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885a7dec-e235-431a-bb5d-eb0eac09370c.pdf",
            "news_date": "2023-02-01 11:13:42",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Q3 FY2022-23 Earnings Call",
            "news_id": "3c5d03f2-bed6-4772-aa92-5e6f23f10345",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773b40a0-f013-4e8c-bf0f-2e7d2de9334c.pdf",
            "news_date": "2023-01-28 15:58:35",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "9335b056-d535-4b8c-ae7a-e627698db306",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e69fa3c-e575-4997-a596-b46ac5ef7de5.pdf",
            "news_date": "2023-01-27 13:27:28",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022<BR> <BR>",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2022.<BR> <BR> The said meeting of the Board commenced at 11.00 a.m. and concluded at 12.30 p.m. <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "b84033f4-3bb0-486d-9580-1dd05b0c655b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ea3f3af-aee5-4f92-9f24-afa494df94d4.pdf",
            "news_date": "2023-01-27 12:55:50",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation - Glenmark Life Sciences Limited Investor Day 2022",
            "news_id": "5ea12521-1828-457f-9c26-5c97cf9f7cf0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fca0df87-b624-46b2-ae30-2337ca312407.pdf",
            "news_date": "2022-11-17 18:33:48",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Further to our communication dated November 11, 2022, attached is a copy of the presentation to be made at Glenmark Life Sciences Limited - Investor Day 2022 which is scheduled today at 15:45 IST in Mumbai.Kindly take the same on record and acknowledge receipt.",
            "news_id": "da62f877-3d1f-4ed7-935a-4c1d7e5abde0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3230e07f-4486-41c8-985e-f19bb2bfd40d.pdf",
            "news_date": "2022-11-17 15:33:04",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI   (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022.Request you to kindly take the same on record.",
            "news_id": "587f127d-058d-4345-9c1c-55e2fbc3f3c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c43edee5-9584-463e-a468-c591daac7d47.pdf",
            "news_date": "2022-11-04 18:22:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdfThe said transcript is also attached.",
            "news_id": "00f9ae3f-199a-4369-8a3d-c4515a8554e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4479f3b7-f07d-40e3-a42e-c65938e2f552.pdf",
            "news_date": "2022-10-27 11:19:17",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3Request you to kindly take the same on record.",
            "news_id": "08707d7c-d85e-42db-be98-b4a22e9957ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13fe9a3a-87ed-4214-94b7-865b4ee8414e.pdf",
            "news_date": "2022-10-22 15:06:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "88d74866-a8a1-4398-95b8-7e5549deeb9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=528a8126-0e2f-4d0c-8473-8c0e7ae51f0e.pdf",
            "news_date": "2022-10-21 13:46:48",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2022.<BR> <BR> The said meeting of the Board commenced at 11.30 a.m. and concluded at 01.10 p.m. <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR>",
            "news_id": "5a424736-bd84-483b-84d8-a86c3219b2cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12560b24-eba9-48ca-84e7-eb65e30941aa.pdf",
            "news_date": "2022-10-21 13:30:14",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, 5th August, 2022 for the quarter ended June 30, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q1%20FY2022-23.pdfRequest you to kindly take the same on record.",
            "news_id": "b525e4de-d452-426d-b725-8835125f8d0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d6593be-3b15-44bf-824a-865d6bd4b634.pdf",
            "news_date": "2022-08-08 16:39:55",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Q1 FY2022-23 Earnings Call Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q1 FY2022-23 Earnings Call held on 5th August, 2022 on the website of the Company at:  https://www.glenmarklifesciences.com/pdf/GLE9320220805142632.mp3",
            "news_id": "f925101b-43c5-46d0-88ed-71d81176a2aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604f198e-f3de-493a-8a83-572dcd804991.pdf",
            "news_date": "2022-08-05 16:15:03",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "4d8c0076-2b0c-42a3-92b6-008025d5f503",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb44fed9-6112-4d3a-94f1-40a8c614607d.pdf",
            "news_date": "2022-08-04 18:54:02",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2022.<BR> <BR> The said meeting of the Board commenced at 3.30 p.m. and concluded at 6.05 p.m.<BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. <BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR>",
            "news_id": "4d4764e7-fecf-4e50-90cb-5277930bd741",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=908ac955-d75a-40ea-a7f8-368430524c01.pdf",
            "news_date": "2022-08-04 18:21:14",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI   (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended March 31, 2022, in the required format.",
            "news_id": "28ac6be4-a811-4355-8051-ce92fe357b2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b66fd59-bf5c-40d6-b92a-a67024e71660.pdf",
            "news_date": "2022-05-31 17:43:11",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recordings Of Q4 & FY22 Earnings Call",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 & FY22 Earnings Call held on April 21, 2022, on our investor website : https://www.glenmarklifesciences.com/financial-results.php under Financial Results.We request you to take note and host the same on your website.",
            "news_id": "b4af379c-0297-4027-b366-94e8cb6f38f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bc92dd-8556-45c3-9832-8065c8545a88.pdf",
            "news_date": "2022-04-22 10:30:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "e44a8f16-4a4d-4a96-a2a0-6c122402cd91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6987bb95-c3c4-4f0a-98d4-d4f006537bab.pdf",
            "news_date": "2022-04-20 20:26:24",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting - April 20, 2022",
            "news_body": "The Board of Glenmark Life Sciences Limited at its meeting held on April 20, 2022, has, inter alia, considered and approved:<BR> <BR> 1. The Audited Financial Results for the Year ended March 31, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the said results together with Management Discussion & Analysis, Press Release, Auditors Report and Declaration of unmodified opinion are enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com.<BR>  <BR> 2. Recommended final Dividend of Rs. 10.50 per share (face value of Rs. 2/- each) on the Equity Share Capital of the Company for the financial year 2021 - 22 subject to the approval of the Shareholders at the ensuing Annual General Meeting.<BR>",
            "news_id": "833f7797-8ecb-4713-b181-db904be2784c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c1ea30f-8d42-444c-b149-d2647efe9edf.pdf",
            "news_date": "2022-04-20 19:35:25",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "540b83f5-2de3-467b-92fa-4f3ab503788d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cca1bea9-a517-4b0d-b76a-15025d40fec5.pdf",
            "news_date": "2022-02-08 19:22:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third<BR> Quarter and Nine Months ended December 31, 2021.<BR> <BR> The said meeting of the Board commenced at 3.30 p.m. and concluded at 6.20 p.m. <BR> <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.",
            "news_id": "f4f86394-fa7a-47f0-8f15-9b55b35e5764",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de065bcf-cc57-4970-9292-63638122b9be.pdf",
            "news_date": "2022-02-08 18:44:19",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.<BR>",
            "news_id": "5ffde5de-7655-44a4-b2e6-370a4931cac0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fc23f73-8248-4c98-8586-ed763b498515.pdf",
            "news_date": "2021-11-10 20:53:47",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting -10Th November, 2021",
            "news_body": "The Board of Directors of Glenmark Life Sciences Limited at its meeting held on November 10, 2021, has, inter alia, considered and approved:<BR> Financial Result:<BR> 1. The Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also<BR> being made available on the website of the Company at www.glenmarkllfesciences.com<BR> Interim Dividend:<BR> 2. Declared an interim dividend of Rs. 10.5/-per equity share of face value of Rs.2/ each for the financial year ending 31st March, 2022. Record date for the purpose of determining<BR> the entitlement of the shareholders for the interim dividend has been fixed as 23rd, November 2021, and dividend will be paid to the shareholders on or after 3rd December, 2021.",
            "news_id": "1157e76b-263f-473a-9705-db1954aba19d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7e43b63-4442-4e91-9988-704e0fc7cb70.pdf",
            "news_date": "2021-11-10 19:29:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2021.<BR> <BR> The said meeting of the Board commenced at 10.00 a.m. and concluded at 12.10 p.m.   <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "b3b942c4-5902-42f5-97a6-beb39935a76b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5bce429-eef8-460a-a323-aaa62270e9e2.pdf",
            "news_date": "2021-08-13 13:19:57",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2021.<BR> <BR> The said meeting of the Board commenced at 10.00 a.m. and concluded at 12.10 p.m.<BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "2cb403e1-c5a9-4ac8-9f99-d2469f9576ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fae44e0-b03a-4040-b77b-527d427bd1fa.pdf",
            "news_date": "2021-08-13 13:16:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}